Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05369325 · ClinicalTrials.gov registry record
Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 200
- Enrollment target
NCT05369325: Completed study, sponsored by Mayo Clinic.
NCT05369325 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05369325 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This research is being done to better understand the accuracy of noninvasive hemoglobin tests on patients that recently underwent total joint arthroplasty.
Primary Outcome
How closely the non-invasive and serum Hgbs correlate with one another statistically
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2023-07-01 |
What the finished NCT05369325 record still lists
NCT05369325 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05369325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05369325 about?
NCT05369325 is a clinical study titled "Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty". This research is being done to better understand the accuracy of noninvasive hemoglobin tests on patients that recently underwent total joint arthroplasty.
What is the current status of trial NCT05369325?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2022-06-15. Estimated completion is 2023-07-01.
Who is sponsoring clinical trial NCT05369325?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI